Dark Forest Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
Other funds holding GBT
Dark Forest Capital Management's GBT Position: Q4 2022 in Review
Dark Forest Capital Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 558 shares — an estimated $38K sold.
Dark Forest Capital Management first reported a position in GBT in Q4 2021 and held it in 2 quarters. The position peaked at $38K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Dark Forest Capital Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Dark Forest Capital Management sold 558 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $38K.
- Dark Forest Capital Management first reported a position in Global Blood Therapeutics, Inc. in Q4 2021 and held it in 2 quarters.
- Dark Forest Capital Management's Global Blood Therapeutics, Inc. position peaked at $38K in Q3 2022.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Dark Forest Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.